Evidence for Progressive Cognitive Deficits in Patients With Major Depressive Disorder
Background: Cognitive deficits have shown progressive feature in major depressive disorder (MDD). However, it remains unknown which component of cognitive function is progressively impaired across episodes of MDD. Here we aim to identify the progressively impaired cognitive components in patients wi...
Main Authors: | , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-02-01
|
Series: | Frontiers in Psychiatry |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fpsyt.2021.627695/full |
id |
doaj-b46da7eccd8c4464999d6bd26af8ba0f |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Jin Liu Jin Liu Bangshan Liu Bangshan Liu Mi Wang Mi Wang Yumeng Ju Yumeng Ju Qiangli Dong Qiangli Dong Xiaowen Lu Xiaowen Lu Jinrong Sun Jinrong Sun Liang Zhang Liang Zhang Hua Guo Futao Zhao Weihui Li Weihui Li Li Zhang Li Zhang Zexuan Li Zexuan Li Yan Zhang Yan Zhang Mei Liao Mei Liao Lingjiang Li Lingjiang Li |
spellingShingle |
Jin Liu Jin Liu Bangshan Liu Bangshan Liu Mi Wang Mi Wang Yumeng Ju Yumeng Ju Qiangli Dong Qiangli Dong Xiaowen Lu Xiaowen Lu Jinrong Sun Jinrong Sun Liang Zhang Liang Zhang Hua Guo Futao Zhao Weihui Li Weihui Li Li Zhang Li Zhang Zexuan Li Zexuan Li Yan Zhang Yan Zhang Mei Liao Mei Liao Lingjiang Li Lingjiang Li Evidence for Progressive Cognitive Deficits in Patients With Major Depressive Disorder Frontiers in Psychiatry major depressive disorder cognitive deficit progression recurrent depression the number of episodes executive function |
author_facet |
Jin Liu Jin Liu Bangshan Liu Bangshan Liu Mi Wang Mi Wang Yumeng Ju Yumeng Ju Qiangli Dong Qiangli Dong Xiaowen Lu Xiaowen Lu Jinrong Sun Jinrong Sun Liang Zhang Liang Zhang Hua Guo Futao Zhao Weihui Li Weihui Li Li Zhang Li Zhang Zexuan Li Zexuan Li Yan Zhang Yan Zhang Mei Liao Mei Liao Lingjiang Li Lingjiang Li |
author_sort |
Jin Liu |
title |
Evidence for Progressive Cognitive Deficits in Patients With Major Depressive Disorder |
title_short |
Evidence for Progressive Cognitive Deficits in Patients With Major Depressive Disorder |
title_full |
Evidence for Progressive Cognitive Deficits in Patients With Major Depressive Disorder |
title_fullStr |
Evidence for Progressive Cognitive Deficits in Patients With Major Depressive Disorder |
title_full_unstemmed |
Evidence for Progressive Cognitive Deficits in Patients With Major Depressive Disorder |
title_sort |
evidence for progressive cognitive deficits in patients with major depressive disorder |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Psychiatry |
issn |
1664-0640 |
publishDate |
2021-02-01 |
description |
Background: Cognitive deficits have shown progressive feature in major depressive disorder (MDD). However, it remains unknown which component of cognitive function is progressively impaired across episodes of MDD. Here we aim to identify the progressively impaired cognitive components in patients with MDD.Methods: A comprehensive neurocognitive test battery was used to assess the cognitive components (executive function, attention, processing speed, memory, working memory, inhibition, shifting, and verbal fluency) in 35 patients with first-episode MDD (FED), 60 patients with recurrent MDD (RD) and 111 matched healthy controls (HCs). After 6 months of treatment with antidepressant, 20 FED and 36 RD patients achieved clinical remission and completed their second-time neurocognitive tests. Statistical analyses were conducted to identify the impaired cognitive components in the FED and RD groups before and after treatment, and to assess the relationship between the cognitive components and the number of episodes and total illness duration in the MDD patient group.Results: At baseline, both the FED and RD groups showed impairments in all of the cognitive components; the FED and RD groups showed no significant difference in all of the components except for shifting. After remission, only shifting in the RD group showed no significant improvement and remained in an impaired status. Furthermore, shifting was the only component negatively correlated with the number of episodes as well as the total illness duration.Conclusions: Shifting may serve as the progressive cognitive deficit across episodes of MDD.Clinical Trials Registration: Registry name: HPA function and MRI study of trauma-related depression; Registration number: ChiCTR1800014591; URL: http://www.chictr.org.cn/edit.aspx?pid=24669&htm=4. |
topic |
major depressive disorder cognitive deficit progression recurrent depression the number of episodes executive function |
url |
https://www.frontiersin.org/articles/10.3389/fpsyt.2021.627695/full |
work_keys_str_mv |
AT jinliu evidenceforprogressivecognitivedeficitsinpatientswithmajordepressivedisorder AT jinliu evidenceforprogressivecognitivedeficitsinpatientswithmajordepressivedisorder AT bangshanliu evidenceforprogressivecognitivedeficitsinpatientswithmajordepressivedisorder AT bangshanliu evidenceforprogressivecognitivedeficitsinpatientswithmajordepressivedisorder AT miwang evidenceforprogressivecognitivedeficitsinpatientswithmajordepressivedisorder AT miwang evidenceforprogressivecognitivedeficitsinpatientswithmajordepressivedisorder AT yumengju evidenceforprogressivecognitivedeficitsinpatientswithmajordepressivedisorder AT yumengju evidenceforprogressivecognitivedeficitsinpatientswithmajordepressivedisorder AT qianglidong evidenceforprogressivecognitivedeficitsinpatientswithmajordepressivedisorder AT qianglidong evidenceforprogressivecognitivedeficitsinpatientswithmajordepressivedisorder AT xiaowenlu evidenceforprogressivecognitivedeficitsinpatientswithmajordepressivedisorder AT xiaowenlu evidenceforprogressivecognitivedeficitsinpatientswithmajordepressivedisorder AT jinrongsun evidenceforprogressivecognitivedeficitsinpatientswithmajordepressivedisorder AT jinrongsun evidenceforprogressivecognitivedeficitsinpatientswithmajordepressivedisorder AT liangzhang evidenceforprogressivecognitivedeficitsinpatientswithmajordepressivedisorder AT liangzhang evidenceforprogressivecognitivedeficitsinpatientswithmajordepressivedisorder AT huaguo evidenceforprogressivecognitivedeficitsinpatientswithmajordepressivedisorder AT futaozhao evidenceforprogressivecognitivedeficitsinpatientswithmajordepressivedisorder AT weihuili evidenceforprogressivecognitivedeficitsinpatientswithmajordepressivedisorder AT weihuili evidenceforprogressivecognitivedeficitsinpatientswithmajordepressivedisorder AT lizhang evidenceforprogressivecognitivedeficitsinpatientswithmajordepressivedisorder AT lizhang evidenceforprogressivecognitivedeficitsinpatientswithmajordepressivedisorder AT zexuanli evidenceforprogressivecognitivedeficitsinpatientswithmajordepressivedisorder AT zexuanli evidenceforprogressivecognitivedeficitsinpatientswithmajordepressivedisorder AT yanzhang evidenceforprogressivecognitivedeficitsinpatientswithmajordepressivedisorder AT yanzhang evidenceforprogressivecognitivedeficitsinpatientswithmajordepressivedisorder AT meiliao evidenceforprogressivecognitivedeficitsinpatientswithmajordepressivedisorder AT meiliao evidenceforprogressivecognitivedeficitsinpatientswithmajordepressivedisorder AT lingjiangli evidenceforprogressivecognitivedeficitsinpatientswithmajordepressivedisorder AT lingjiangli evidenceforprogressivecognitivedeficitsinpatientswithmajordepressivedisorder |
_version_ |
1724268062429937664 |
spelling |
doaj-b46da7eccd8c4464999d6bd26af8ba0f2021-02-16T05:35:29ZengFrontiers Media S.A.Frontiers in Psychiatry1664-06402021-02-011210.3389/fpsyt.2021.627695627695Evidence for Progressive Cognitive Deficits in Patients With Major Depressive DisorderJin Liu0Jin Liu1Bangshan Liu2Bangshan Liu3Mi Wang4Mi Wang5Yumeng Ju6Yumeng Ju7Qiangli Dong8Qiangli Dong9Xiaowen Lu10Xiaowen Lu11Jinrong Sun12Jinrong Sun13Liang Zhang14Liang Zhang15Hua Guo16Futao Zhao17Weihui Li18Weihui Li19Li Zhang20Li Zhang21Zexuan Li22Zexuan Li23Yan Zhang24Yan Zhang25Mei Liao26Mei Liao27Lingjiang Li28Lingjiang Li29Department of Psychiatry, The Second Xiangya Hospital, Central South University, Changsha, ChinaHunan Key Laboratory of Psychiatry and Mental Health, China National Clinical Research Center on Mental Disorders (Xiangya), China National Technology Institute on Mental Disorders, Hunan Technology Institute of Psychiatry, Mental Health Institute of Central South University, Changsha, ChinaDepartment of Psychiatry, The Second Xiangya Hospital, Central South University, Changsha, ChinaHunan Key Laboratory of Psychiatry and Mental Health, China National Clinical Research Center on Mental Disorders (Xiangya), China National Technology Institute on Mental Disorders, Hunan Technology Institute of Psychiatry, Mental Health Institute of Central South University, Changsha, ChinaDepartment of Psychiatry, The Second Xiangya Hospital, Central South University, Changsha, ChinaHunan Key Laboratory of Psychiatry and Mental Health, China National Clinical Research Center on Mental Disorders (Xiangya), China National Technology Institute on Mental Disorders, Hunan Technology Institute of Psychiatry, Mental Health Institute of Central South University, Changsha, ChinaDepartment of Psychiatry, The Second Xiangya Hospital, Central South University, Changsha, ChinaHunan Key Laboratory of Psychiatry and Mental Health, China National Clinical Research Center on Mental Disorders (Xiangya), China National Technology Institute on Mental Disorders, Hunan Technology Institute of Psychiatry, Mental Health Institute of Central South University, Changsha, ChinaDepartment of Psychiatry, The Second Xiangya Hospital, Central South University, Changsha, ChinaHunan Key Laboratory of Psychiatry and Mental Health, China National Clinical Research Center on Mental Disorders (Xiangya), China National Technology Institute on Mental Disorders, Hunan Technology Institute of Psychiatry, Mental Health Institute of Central South University, Changsha, ChinaDepartment of Psychiatry, The Second Xiangya Hospital, Central South University, Changsha, ChinaHunan Key Laboratory of Psychiatry and Mental Health, China National Clinical Research Center on Mental Disorders (Xiangya), China National Technology Institute on Mental Disorders, Hunan Technology Institute of Psychiatry, Mental Health Institute of Central South University, Changsha, ChinaDepartment of Psychiatry, The Second Xiangya Hospital, Central South University, Changsha, ChinaHunan Key Laboratory of Psychiatry and Mental Health, China National Clinical Research Center on Mental Disorders (Xiangya), China National Technology Institute on Mental Disorders, Hunan Technology Institute of Psychiatry, Mental Health Institute of Central South University, Changsha, ChinaDepartment of Psychiatry, The Second Xiangya Hospital, Central South University, Changsha, ChinaHunan Key Laboratory of Psychiatry and Mental Health, China National Clinical Research Center on Mental Disorders (Xiangya), China National Technology Institute on Mental Disorders, Hunan Technology Institute of Psychiatry, Mental Health Institute of Central South University, Changsha, ChinaZhumadian Psychiatric Hospital, Zhumadian, ChinaZhumadian Psychiatric Hospital, Zhumadian, ChinaDepartment of Psychiatry, The Second Xiangya Hospital, Central South University, Changsha, ChinaHunan Key Laboratory of Psychiatry and Mental Health, China National Clinical Research Center on Mental Disorders (Xiangya), China National Technology Institute on Mental Disorders, Hunan Technology Institute of Psychiatry, Mental Health Institute of Central South University, Changsha, ChinaDepartment of Psychiatry, The Second Xiangya Hospital, Central South University, Changsha, ChinaHunan Key Laboratory of Psychiatry and Mental Health, China National Clinical Research Center on Mental Disorders (Xiangya), China National Technology Institute on Mental Disorders, Hunan Technology Institute of Psychiatry, Mental Health Institute of Central South University, Changsha, ChinaDepartment of Psychiatry, The Second Xiangya Hospital, Central South University, Changsha, ChinaHunan Key Laboratory of Psychiatry and Mental Health, China National Clinical Research Center on Mental Disorders (Xiangya), China National Technology Institute on Mental Disorders, Hunan Technology Institute of Psychiatry, Mental Health Institute of Central South University, Changsha, ChinaDepartment of Psychiatry, The Second Xiangya Hospital, Central South University, Changsha, ChinaHunan Key Laboratory of Psychiatry and Mental Health, China National Clinical Research Center on Mental Disorders (Xiangya), China National Technology Institute on Mental Disorders, Hunan Technology Institute of Psychiatry, Mental Health Institute of Central South University, Changsha, ChinaDepartment of Psychiatry, The Second Xiangya Hospital, Central South University, Changsha, ChinaHunan Key Laboratory of Psychiatry and Mental Health, China National Clinical Research Center on Mental Disorders (Xiangya), China National Technology Institute on Mental Disorders, Hunan Technology Institute of Psychiatry, Mental Health Institute of Central South University, Changsha, ChinaDepartment of Psychiatry, The Second Xiangya Hospital, Central South University, Changsha, ChinaHunan Key Laboratory of Psychiatry and Mental Health, China National Clinical Research Center on Mental Disorders (Xiangya), China National Technology Institute on Mental Disorders, Hunan Technology Institute of Psychiatry, Mental Health Institute of Central South University, Changsha, ChinaBackground: Cognitive deficits have shown progressive feature in major depressive disorder (MDD). However, it remains unknown which component of cognitive function is progressively impaired across episodes of MDD. Here we aim to identify the progressively impaired cognitive components in patients with MDD.Methods: A comprehensive neurocognitive test battery was used to assess the cognitive components (executive function, attention, processing speed, memory, working memory, inhibition, shifting, and verbal fluency) in 35 patients with first-episode MDD (FED), 60 patients with recurrent MDD (RD) and 111 matched healthy controls (HCs). After 6 months of treatment with antidepressant, 20 FED and 36 RD patients achieved clinical remission and completed their second-time neurocognitive tests. Statistical analyses were conducted to identify the impaired cognitive components in the FED and RD groups before and after treatment, and to assess the relationship between the cognitive components and the number of episodes and total illness duration in the MDD patient group.Results: At baseline, both the FED and RD groups showed impairments in all of the cognitive components; the FED and RD groups showed no significant difference in all of the components except for shifting. After remission, only shifting in the RD group showed no significant improvement and remained in an impaired status. Furthermore, shifting was the only component negatively correlated with the number of episodes as well as the total illness duration.Conclusions: Shifting may serve as the progressive cognitive deficit across episodes of MDD.Clinical Trials Registration: Registry name: HPA function and MRI study of trauma-related depression; Registration number: ChiCTR1800014591; URL: http://www.chictr.org.cn/edit.aspx?pid=24669&htm=4.https://www.frontiersin.org/articles/10.3389/fpsyt.2021.627695/fullmajor depressive disordercognitive deficitprogressionrecurrent depressionthe number of episodesexecutive function |